Global biopharmaceutical leader UCB selects IDBS’ BioBook for DMPK and Pharmacology

11 Feb 2008
Greg Smith
Analyst / Analytical Chemist

IDBS today announced that the global biopharmaceutical company UCB has licensed BioBook to be deployed across multiple European sites for DMPK (Drug Metabolism and Pharmacokinetics) and pharmacology.

UCB focuses on developing breakthrough treatments for severe diseases within selected therapeutic areas such as neurological disorders, inflammatory diseases and oncology. UCB, which transformed into a pure biopharma during 2005, required a complete solution for managing late stage biological research data. The decision to invest in BioBook was based on the product’s flexible structure and its ability to capture complex data in one application, eliminating transcription errors and providing a better quality of data.

Hector Sanchez, Senior Director R&D Informatics, UCB, commented: “IDBS’ ActivityBase is our company repository primarily for all our screening data. However, for DMPK and pharmacology we required a solution that would capture both structured and unstructured data which is why we selected BioBook for these disciplines. This combination of IDBS products gives us the best of both worlds and provides a complete view on our data, reducing experiment duplication, sharing data across the organization and freeing scientists from report creation, giving them back vital research hours.”

Neil Kipling, founder and CEO of IDBS, commented: “Because of the types of data captured during DMPK and pharmacology studies, these critical research areas are often neglected by other informatics providers. Many data management solutions are not specific or flexible enough to handle this complex data. IDBS recognized this problem and therefore developed BioBook which provides a tool specifically designed with the needs of these therapeutic areas in mind.” He added: “BioBook delivers the benefits of IP protection, workflow support, compliance and enhanced report generation, as well as offering specific functionality for the biologist.”

BioBook (E-WorkBook for biology)

IDBS

BioBook (E-WorkBook for biology) delivers complete late stage discovery and early preclinical research data management. Offering a compliant environment with superior flexibility, BioBook (E-WorkBook for biology) simplifies the capture, analysis and reporting of complex, multi-dimensional experimental data, with interactive complex statistics and graphing. BioBook is a robust and easy to use application that controls every stage of the study lifecycle, from organizing and designing experiments, capturing data, to generating and sharing reports. BioBook enhances the productivity of biologists who run low throughput and preclinical assays, and enables global access to protocols, data, results and their interpretation. Specific tools developed for data capture and analysis and included as standard in BioBook are: • Experimental design and randomization • Data knockout/knock in • Data blinding • Dynamic curve fitting and advanced statistical analysis • Interactive charts and data visualization BioBook also provides the researcher with: • A multi-dimensional spreadsheet in a compliant environment • Report generation tool that enables the rapid production of study reports • Facility to import and export protocol-based data to corporate repositories • Experimental templates easily set up by the scientist • Data capture and import from laboratory instruments • The ability to perform complex search queries, or free text search of all data including embedded documents such as Microsoft® Word and Excel

(0)

Links

Tags

Global biopharmaceutical leader UCB selects IDBS’ BioBook for DMPK and Pharmacology